Related Experiment Video

Updated: Jun 9, 2026

Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease
09:33

Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease

Published on: December 26, 2016

7.9K

Late onset Alzheimer's disease: modeling disease hallmarks via in vitro 3D iNeuron cultures

Giacomo Masserdotti1,2

  • 1Institute of Stem Cell Research, Helmholtz Center Munich, 85764, Neuherberg, Germany. giacomo.masserdotti@helmholtz-munich.de.

Signal Transduction and Targeted Therapy
|October 10, 2024
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Fabrication of Amyloid-β-Secreting Alginate Microbeads for Use in Modelling Alzheimer's Disease
06:52

Fabrication of Amyloid-β-Secreting Alginate Microbeads for Use in Modelling Alzheimer's Disease

Published on: July 6, 2019

9.3K
Author Spotlight: Advancing 3D Cell Modeling – A High-Throughput Approach for Neural Cocultures
08:03

Author Spotlight: Advancing 3D Cell Modeling – A High-Throughput Approach for Neural Cocultures

Published on: September 29, 2023

4.4K

Related Experiment Videos

Last Updated: Jun 9, 2026

Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease
09:33

Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease

Published on: December 26, 2016

7.9K
Fabrication of Amyloid-β-Secreting Alginate Microbeads for Use in Modelling Alzheimer's Disease
06:52

Fabrication of Amyloid-β-Secreting Alginate Microbeads for Use in Modelling Alzheimer's Disease

Published on: July 6, 2019

9.3K
Author Spotlight: Advancing 3D Cell Modeling – A High-Throughput Approach for Neural Cocultures
08:03

Author Spotlight: Advancing 3D Cell Modeling – A High-Throughput Approach for Neural Cocultures

Published on: September 29, 2023

4.4K

Related Concept Videos

Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...

Articles linked to this work by shared authors, journal, and citation graph.

Single Cell Deletion of the Transcription Factors Trps1 and Sox9 in Astrocytes Reveals Novel Functions in the Adult Cerebral Cortex.

Glia·2024

Comparing Viral Vectors and Fate Mapping Approaches for Astrocyte-to-Neuron Reprogramming in the Injured Mouse Cerebral Cortex.

Cells·2024

Direct neuronal reprogramming of mouse astrocytes is associated with multiscale epigenome remodeling and requires Yy1.

Nature neuroscience·2024

Injury-specific factors in the cerebrospinal fluid regulate astrocyte plasticity in the human brain.

Nature medicine·2023

Primary Aldosteronism: Spatial Multiomics Mapping of Genotype-Dependent Heterogeneity and Tumor Expansion of Aldosterone-Producing Adenomas.

Hypertension (Dallas, Tex. : 1979)·2023

Vascular calcification: pathogenic mechanisms, signaling crosstalk and translational therapeutics.

Signal transduction and targeted therapy·2026

The gasdermin family: from pyroptosis mechanisms to therapeutic targets.

Signal transduction and targeted therapy·2026

Chimeric antigen receptor T (CAR-T) cell therapy in non-oncological diseases.

Signal transduction and targeted therapy·2026

Carbon nanoparticle-Fe (II) complex for ferroptosis therapy in refractory solid tumors: a phase I trial.

Signal transduction and targeted therapy·2026

Cell differentiation-related signaling pathways: biological functions, diseases and therapeutic targets.

Signal transduction and targeted therapy·2026

Targeting the HPGDS-PGD2 axis to treat Th17 cell-mediated autoimmunity in multiple sclerosis.

Signal transduction and targeted therapy·2026

New FDA-Approved Treg Therapy to Reduce Chronic GVHD After Allogeneic HSCT.

Blood·2026

Zinc ion-releasing immunomodulatory hydrogels for enhanced wound healing.

Regenerative biomaterials·2026

Correction: TGFB2-mediated regeneration of pelvic ligament equivalents using a stem cell-fibroblast-decellularized membrane composite.

Frontiers in bioengineering and biotechnology·2026

Multifunctional pH-responsive HA-c-FZ1 hydrogel presents a promising therapeutic strategy for diabetic skin wounds.

Burns & trauma·2026

Correction: Characterization of the roles of amphiregulin and transforming growth factor β1 in microvasculature-like formation in human granulosa-lutein cells.

Frontiers in cell and developmental biology·2026

Stronger Together: Isograft Fusion Accelerates Recovery and May Facilitate Heat-Evolved Symbiont Transmission in Bleached Adult Corals.

Environmental microbiology reports·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us